24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Helsinn
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:10
Rinki Sethi, former Twitter and Walmart CISO, joins cloud security startup Upwind
14:28
Full list of Israeli high-tech funding rounds in 2025
14:24
Israel’s Beewise raises $50 million to save bees, and the global food chain
12:39
Hamilton Lane launches evergreen funds in Israel to provide new access to private markets
More stories
Buzz
Most popular
Daily
Weekly
1
Andreessen Horowitz targets elite IDF alumni for startup accelerator
2
Cyera doubles valuation to $6 billion with $540M Series E
3
eToro’s Wall Street honeymoon ends abruptly after first earnings call
4
Vast Data eyes $25 billion valuation amid AI boom
5
Tastewise raises $50M to power the AI brain behind Kraft, Mars, and Campbell’s
More news
Helsinn
1 stories about Helsinn
Teva's Swiss Anti-Nausea Drug Patent Suit Reaches U.S. Supreme Court
05.12.18
|
Lilach Baumer
Teva was sued in 2011 by Swiss drug company Helsinn Healthcare over its intention to develop a generic version of Helsin's drug, which it released in the U.S. in March 2018